Location History:
- Houston, TX (US) (1976)
- Missouri City, TX (US) (1979)
- Centreville, LA (US) (1979)
- Midland, MI (US) (1991)
- Pittsburg, CA (US) (1992)
- San Jose, CA (US) (2000 - 2002)
- Baltimore, MD (US) (2015 - 2017)
Company Filing History:
2 out of 13,684 
2 out of 191 
1 out of 8 
Years Active: 1976-2017
Title: The Innovative Mind of James Sinclair: Pioneering Shiga Toxin Research
Introduction
James Sinclair is a notable inventor based in San Jose, California, boasting an impressive portfolio of 10 patents. His work primarily revolves around methods and compositions based on Shiga toxin type 2 protein, showcasing his dedication to advancing medical science and public health.
Latest Patents
Sinclair's latest patents focus on the discovery of the epitope in the Stx2 protein for the 11 E1O antibody. His inventions feature compositions containing non-full-length Stx2 polypeptides that include the 11 E1O monoclonal antibody epitope. Furthermore, these inventions include methods for producing anti-Stx2 antibodies specific for this epitope. Sinclair's patents also present innovative methods for treating individuals at risk of developing Shiga toxin-associated diseases, such as hemolytic uremic syndrome. He has created polypeptides that incorporate the 11 E1O epitope and developed antibodies aimed at combating the effects of Shiga toxins. Additionally, his inventions aid in the detection of Stx2 in samples using the antibodies he has developed.
Career Highlights
Throughout his career, Sinclair has made significant contributions to the medical field through his innovative research and patenting efforts. His focus on Shiga toxin type 2 and its implications for public health reflects his commitment to combating infectious diseases. He has worked with prominent companies such as Applied Materials, Inc., further enhancing his experience in the field.
Collaborations
James Sinclair is known for collaborating with esteemed colleagues, including Lawrence L. Lee and Alison D. O'Brien. These partnerships have bolstered his research efforts and expanded the impact of his innovations in the study and treatment of Shiga toxin-related conditions.
Conclusion
In summary, James Sinclair stands out as a pioneering inventor whose work on Shiga toxin type 2 protein has the potential to significantly influence the treatment and detection of various diseases. With his extensive patent portfolio and collaborative initiatives, Sinclair continues to be a prominent figure in the realm of medical innovations.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.